Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-039104
Filing Date
2019-06-26
Accepted
2019-06-26 16:30:58
Documents
1
Period of Report
2019-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4798
  Complete submission text file 0001209191-19-039104.txt   6201
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Issuer) CIK: 0001175505 (see all company filings)

EIN.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FIVE PRIME THERAPEUTICS, INC. 2 CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Sarena Francis Willard (Reporting) CIK: 0001423786 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36070 | Film No.: 19921981